Table 1. Relationship between miR-149 expression and clinical pathological factors in glioma cancer.
Variable | Patients | negative | positive | p value | ||
---|---|---|---|---|---|---|
+ | ++ | +++ | ||||
Gender | ||||||
Male | 50 | 13 (26%) | 28 | 8 | 1 | 0.3152 a |
Female | 32 | 6 (18.8%) | 19 | 7 | 0 | |
Age | ||||||
< = 40 | 36 | 5 (13.9%) | 23 | 7 | 1 | 0.1135 a |
> 40 | 46 | 14 (30.4%) | 24 | 8 | 0 | |
Pathological stage | ||||||
normal | 10 | 4 (40%) | 2 | 3 | 1 | 0.0084 a |
tumor | 72 | 15 (20.8%) | 45 | 12 | 0 | |
1 | 7 | 0 (0.0%) | 4 | 3 | 0 | 0.0114 a |
II | 47 | 15 (31.9%) | 24 | 8 | 0 | |
III | 9 | 0 (0.0%) | 8 | 1 | 0 | |
IV | 9 | 0 (0.0%) | 9 | 0 | 0 |
Two-sided Fisher's Exact Test.